ABBEVILLE GENERAL HOSPITAL — History
CCN 190034 | 3-year financial timeline | COVID resilience: 80/100
🛡️ Public data only — no PHI permitted on this instance.
$68M
Latest Revenue (FY2022)
+12.9%
Revenue CAGR (3yr)
3.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $54M | $59M | $68M | +15.6% | +12.9% |
| Operating Expenses | $56M | $62M | $66M | +6.6% | +8.4% |
| Operating Margin | -4.8% | -4.7% | 3.4% | +172.1% | +0.0% |
| Net Income | $-3M | $-3M | $2M | +183.4% | +0.0% |
| Licensed Beds | 44 | 44 | 44 | +0.0% | +0.0% |
| Total Patient Days | 5,802 | 6,883 | 6,577 | -4.4% | +6.5% |
| Medicare Day % | 40% | 35% | 32% | -9.6% | -11.2% |
| Medicaid Day % | 1% | 1% | 1% | -22.5% | -30.9% |
COVID Impact & Recovery
Resilience Score: 80/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +27.5% ($54M → $68M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+12.9%
This Hospital
+7.6%
State Avg
Latest Margin
3.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $76M | 7.5% |
| FY2024 (proj) | $83M | 11.6% |
| FY2025 (proj) | $91M | 15.6% |